FOR CLINICIANS AND ASCs

Your patients show up.
ZeraFlow makes sure
they are ready.

A clinic-controlled, nurse-supervised bowel preparation system. Predictable results. Fewer cancellations. Cleaner procedures.

THE PROBLEM

Inadequate prep is not a patient problem. It is a system problem.

18–35%

of colonoscopies are compromised by inadequate bowel preparation in real-world practice — and you will not know until the scope is inserted.

10–15%

of scheduled procedures are cancelled or delayed on the day of the procedure due to prep failure, directly impacting revenue and schedule efficiency.

47%

reduction in small adenoma detection in poorly prepped colons — undermining the clinical value of every compromised procedure.

$1,100–$2,500

cost of a single repeat colonoscopy due to poor prep — a direct consequence of a system that relies entirely on unsupervised at-home compliance.

CLINICAL OUTCOMES

International clinical data across 500+ procedures

97%

Prep adequacy rate (BBPS)

98.4%

Patient completion rate

Zero

Serious adverse events reported

~10 min

Estimated procedure time saved per colonoscopy

All data based on international clinical use. ZeraFlow is an investigational device not cleared by the U.S. FDA. U.S. clinical pilot in development.

Integrates into your existing workflow in four steps

  • Patient arrives

    Three mild tablets the night before. No large-volume oral prep required.

  • Prep room (~200 sq ft)

    Standard water connection and drainage outlet. Minimal space required.

  • RN-supervised cleanse

    30-60 min warm-water irrigation. Single-use sleeve. Full-colon cleansing confirmed.

  • Proceed to colonoscopy

    Prep adequacy confirmed before scope insertion. Clean colon, every time.

PRACTICE ECONOMICS

ZeraFlow converts prep from a liability into a revenue-generating clinical step

Traditional oral prep ZeraFlow
What you drink 2–4 liters of solution at home Nothing to drink at home
Where prep happens At home, alone, uncontrolled At the clinic, nurse-supervised
Time commitment 12–24 hours of disruption About 30 minutes
Side effects Nausea, bloating, sleep disruption Warm water, minimal discomfort
Dignity Hours on the toilet, alone Private, supervised clinical setting
Back to normal Often the next day or later Same day
Prep adequacy 65–82% adequate (real-world) 97% adequate (international data)

We are selecting our first U.S. clinic partners.

  • White-glove onboarding

    Equipment installation, workflow integration, and on-site launch support.

  • RN training and certification

    Full nurse training program included at no additional cost.

  • Ongoing clinical support

    Real-time clinical and operational guidance throughout the pilot.

Express Pilot Interest

Tell us about your practice

We are completing FDA clearance and selecting our first U.S. clinic partners. Enter your information and we will notify you as soon as ZeraFlow is available near you.